CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Company's retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Care Plans
  • Sub-Industry: Drug Retail
  • Exchange: NYSE
  • Symbol: CVS
  • CUSIP: 12665010
Key Metrics:
  • Previous Close: $93.78
  • 50 Day Moving Average: $96.36
  • 200 Day Moving Average: $98.52
  • Trailing P/E Ratio: 21.45
  • Foreward P/E Ratio: 14.17
  • P/E Growth: 1.10
  • Market Cap: $99.44B
  • Outstanding Shares: 1,066,214,000
  • Beta: 0.82
Additional Links:
Companies Related to CVS Health Corporation:

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (?)
Ratings Breakdown: 4 Hold Ratings, 17 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $113.78 (22.01% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetDetails
8/8/2016Citigroup Inc.Lower Price TargetNeutral$115.00 -> $108.00View Rating Details
8/4/2016ArgusReiterated RatingBuy$120.00View Rating Details
8/4/2016MizuhoBoost Price TargetBuy$108.00 -> $111.00View Rating Details
8/3/2016Leerink SwannReiterated RatingBuyView Rating Details
8/3/2016Morgan StanleyReiterated RatingHold$104.00View Rating Details
8/3/2016Deutsche Bank AGBoost Price TargetHold$99.00 -> $108.00View Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00View Rating Details
7/4/2016Jefferies GroupReiterated RatingBuyView Rating Details
6/5/2016Credit Suisse Group AGReiterated RatingBuy$115.00View Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00View Rating Details
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00View Rating Details
3/10/2016Barclays PLCBoost Price TargetOverweight$110.00 -> $115.00View Rating Details
2/10/2016GuggenheimLower Price TargetBuy$120.00 -> $115.00View Rating Details
2/10/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$106.00 -> $110.00View Rating Details
2/3/2016Atlantic SecuritiesInitiated CoverageOverweight$114.00View Rating Details
1/22/2016Robert W. BairdInitiated CoverageOutperform$108.00View Rating Details
12/18/2015Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00View Rating Details
11/2/2015Raymond James Financial Inc.Boost Price TargetOutperform$105.00 -> $110.00View Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00View Rating Details
11/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 -> $123.00View Rating Details
10/30/2015Evercore ISILower Price TargetBuy$111.00 -> $110.00View Rating Details
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00View Rating Details
2/11/2015Cantor FitzgeraldReiterated RatingHold$83.00View Rating Details
2/10/2015Noble FinancialReiterated RatingOutperformView Rating Details
1/21/2015StephensInitiated CoverageOverweightView Rating Details
1/2/2015Bank of America Corp.Set Price TargetBuy$94.00 -> $104.00View Rating Details
12/19/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$92.00 -> $110.00View Rating Details
(Data available from 8/28/2014 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.20$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
Current Year EPS Consensus Estimate: $5.87 EPS
Next Year EPS Consensus Estimate: $6.58 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.15$1.19$1.17
Q2 20166$1.30$1.36$1.31
Q3 20165$1.56$1.58$1.57
Q4 20165$1.77$1.80$1.79
Q1 20173$1.33$1.34$1.34
Q2 20173$1.48$1.59$1.52
Q3 20173$1.71$1.75$1.73
Q4 20173$1.91$2.00$1.97
Q1 20181$1.49$1.49$1.49
Q2 20181$1.62$1.62$1.62
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Annual Dividend:$1.70
Dividend Yield:1.82%
Payout Ratio:39.08% (Based on Trailing 12 Months of Earnings)
28.96% (Based on Current Year Consensus EPS Estimate)
25.84% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:29.10% (3 Year Average)

Dividend History for CVS Health Corporation (NYSE:CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CVS Health Corporation (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline logoMylan's EpiPen Price 'Cut' An Outdated Drug Industry PR Move (NYSE:CVS) - August 28 at 9:04 AM logoCVS Health Corporation (CVS) Recommended at Buy on EpiPen Associated Weakness: Leerink - TCC (NYSE:CVS) - August 27 at 9:24 AM logoCVS Health : Fighting Opioid Abuse with Technology (NYSE:CVS) - August 26 at 4:40 PM logoEpiPen pricing under fire (NYSE:CVS) - August 26 at 4:40 PM logoTalent Is Ageless (NYSE:CVS) - August 26 at 4:40 PM logoExpress Scripts: Is EpiPen Reaction Overblown? (NYSE:CVS) - August 26 at 4:40 PM logoPharmacy owner: There's a huge issue with PBMs (NYSE:CVS) - August 26 at 4:40 PM logoFighting Opioid Abuse with Technology (NYSE:CVS) - August 26 at 4:40 PM
News IconLeading stocks in today’s market: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - August 26 at 9:10 AM logoCVS Health Corporation (CVS) Recommended at Buy on EpiPen Associated Weakness: Leerink (NYSE:CVS) - August 26 at 9:10 AM logoHere's How to Trade CVS After Its Breakdown (NYSE:CVS) - August 26 at 9:10 AM logoCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : August 26, 2016 (NYSE:CVS) - August 26 at 9:10 AM
News IconAnalyst Review Alert on Price Target: CVS Health Corp (NYSE:CVS) - Post Registrar (NYSE:CVS) - August 25 at 9:49 PM
News IconHC Stocks Indications: CVS Health Corp (CVS), Nymox Pharmaceutical Corporation (NYMX) - share market updates (press release) (NYSE:CVS) - August 25 at 9:29 AM
News IconAnalysts Valuations For Two Stocks: CVS Health Corp (NYSE:CVS), EOG Resources Inc (NYSE:EOG) - The Voice Registrar (NYSE:CVS) - August 24 at 4:29 PM logoCVS Health : and Easterseals Celebrate Ten Years of Partnership to Support our Nation's Young Children on Their Path to Better Health (NYSE:CVS) - August 24 at 8:41 AM
News IconStock Grabbing Investor's Attention: CVS Health Corporation (NYSE:CVS), Tyson Foods, Inc. (NYSE:TSN) - Newburg Press (NYSE:CVS) - August 23 at 9:40 PM
News IconInvestor's Watch List: 3D Systems Corporation (NYSE:DDD), CVS Health Corp (NYSE:CVS) - NYSE Journal (press release) (NYSE:CVS) - August 23 at 9:40 PM logoCVS Health Breaks Above 200-Day Moving Average - Bullish for CVS (NYSE:CVS) - August 23 at 8:43 AM
News IconUpdate on CVS Health Corporation (NYSE:CVS) for the day (NYSE:CVS) - August 23 at 8:43 AM
News IconStock Trading Above Moving Averages: CVS Health Corporation (NYSE:CVS) - Post News (NYSE:CVS) - August 22 at 4:35 PM
News IconMovers to Watch: CVS Health Corp (NYSE:CVS), Zoetis Inc (NYSE:ZTS) - Post Registrar (NYSE:CVS) - August 22 at 4:35 PM logoCVS Health : teams up with Roca to provide at-risk women with career training (NYSE:CVS) - August 22 at 9:11 AM logoCVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to Specific Patient Populations (NYSE:CVS) - August 22 at 9:11 AM
News IconHealth Care Plans: CVS Health Corporation (NYSE:CVS) Position of the day (NYSE:CVS) - August 20 at 4:30 PM logoCVS Health Corporation (NYSE:CVS): The Buzzing Stock (NYSE:CVS) - August 20 at 4:30 PM
News IconAnalysts Valuations For Two Stocks: CVS Health Corp (NYSE:CVS), 3M Co (NYSE:MMM) - The Voice Registrar (NYSE:CVS) - August 19 at 8:37 PM
News IconStocks Defying Gravity- CVS Health Corporation (NYSE:CVS ... - Street Wise Report (press release) (blog) (NYSE:CVS) - August 19 at 8:37 PM
News IconHealth Care Plans: CVS Health Corporation (NYSE:CVS) Position of the day - Twin County News (NYSE:CVS) - August 19 at 3:36 PM logoMoody's Upgrades One, Affirms One, and Downgrades One Class of FUNCM 1999-C2 (NYSE:CVS) - August 19 at 3:36 PM
News IconRegions Financial (NYSE:RF) & CVS Health Corp (NYSE:CVS) Sizzling Stocks Alert - Money News (press release) (NYSE:CVS) - August 19 at 9:36 AM
News IconTarget Corporation (NYSE:TGT) & CVS Health Corp (NYSE:CVS) Stocks are Roundup - Money News (press release) (NYSE:CVS) - August 18 at 4:34 PM logoCVS Health and the CVS Health Foundation Announce $100K Donation In Support of Louisiana Flood Relief Efforts (NYSE:CVS) - August 18 at 4:34 PM logoCVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Colorado (NYSE:CVS) - August 18 at 4:34 PM logoRenTech Loaded Up On Mastercard, Nike, More in Q2 (NYSE:CVS) - August 18 at 4:34 PM logoWhy Selling Drugs Has Gotten Tougher for Target (NYSE:CVS) - August 18 at 9:25 AM logoCVS Health Corporation in 5 Charts - Motley Fool (NYSE:CVS) - August 17 at 9:52 PM logoCramer: Target's Excuses Really Don't Cut It (NYSE:CVS) - August 17 at 9:52 PM
News IconLarge Cap Health Care Plans: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - August 17 at 4:42 PM
News IconTop Gainers of the Day: CVS Health Corporation (NYSE:CVS) from Health Care Plans (NYSE:CVS) - August 17 at 9:25 AM logoCVS Health Survey Reveals Two in Five Americans Make Multiple Trips to get Entire Household Vaccinated against the Flu (NYSE:CVS) - August 16 at 4:33 PM logoCVS Health Corporation in 5 Charts (NYSE:CVS) - August 16 at 4:33 PM logo5 Stocks to Watch Before the Market Opens Tomorrow (NYSE:CVS) - August 16 at 4:33 PM logoCan Target Withstand Amazon’s Wrath? (NYSE:CVS) - August 16 at 4:33 PM logoWhat CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio (NYSE:CVS) - August 15 at 4:42 PM
News IconCVS Health Corp (NYSE:CVS) & XPO Logistics Inc (NYSE:XPO) Stocks in the News (NYSE:CVS) - August 15 at 11:46 AM logoETF’s with exposure to CVS Health Corp. : August 15, 2016 (NYSE:CVS) - August 15 at 11:46 AM logo70 or Older? 3 Stocks You Should Consider Buying (NYSE:CVS) - August 14 at 9:13 AM logoFriday links: unsolvable puzzles (NYSE:CVS) - August 12 at 4:30 PM logoCVS Health : Makes Overdose-Reversal Drug Naloxone Available Without A Prescription in Idaho (NYSE:CVS) - August 12 at 9:37 AM


CVS Health Corporation (NYSE:CVS) Chart for Sunday, August, 28, 2016

Last Updated on 8/28/2016 by Staff